Abstract:Background: No effective drugs for the treatment of sepsis-induced diaphragm dysfunction are currently available. Therefore, it is particularly important to clarify the molecular regulatory mechanism of this condition and subsequently implement effective treatment and prevention of sepsis-induced diaphragm dysfunction. Methods: A mouse model of diaphragm dysfunction was established via injection of lipopolysaccharide (LPS). An RNA-sequencing (RNA-seq) technique was used to detect the differentially expressed genes (DEGs) in the diaphragms of mice. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed for functional analysis of DEGs. The protein-protein interaction network obtained from the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) website was imported into Cytoscape, the key molecular regulatory network was constructed with CytoNCA, the ClueGo plugin was further used to analyze the core regulatory pathways of key molecular, and finally, the iRegulon plugin was used to the identify key transcription factors. Results: The genes upregulated after LPS treatment were involved in biological processes and pathways related to immune response; the genes downregulated after LPS treatment were mainly correlated with the muscle contraction. The expressions of several inflammation-related genes were upregulated after LPS treatment, of which tumor necrosis factor (Tnf), interleukin (Il)-1β, and Il-6 assumed a core regulatory role in the network; meanwhile, the downregulated key genes included Col1a1, Uqcrfs1, Sdhb, and ATP5a1, among others. These key regulatory factors participated in the activation of Toll-like receptor (TLR) signaling pathway, nuclear factor (NF)-κB signaling pathway, and TNF signaling pathway as well as the inhibition of oxidative phosphorylation pathway, cardiac muscle contraction pathway, and citrate cycle pathway. Finally, RelA, IRF1, and STAT3, were identified as the key regulators in the early stage of diaphragmatic inflammatory response. Conclusions: Sepsis-induced diaphragm dysfunction in mice is closely correlated with the activation of TLR signaling pathway, NF-κB signaling pathway, and TNF signaling pathway and the inhibition of oxidative phosphorylation pathway, cardiac muscle contraction pathway, and citrate cycle pathway. Our findings provide insight into the molecular mechanism of sepsis-induced diaphragm dysfunction in mice and provide a promising new strategy for targeted treatment of diaphragm dysfunction.

Beneficial Effects of Dantrolene on Sepsis-Induced Diaphragmatic Dysfunction Are Associated with Downregulation of High-Mobility Group Box 1 and Calpain-Caspase-3 Proteolytic Pathway.

Effects of Dantrolene Pretreatment on Diaphragmatic Function in Septic Rats

Lowered Sarcoendoplasmic Reticulum Calcium Uptake and Diaphragmatic SERCA1 Expression Contribute to Diaphragmatic Contractile and Relaxation Dysfunction in Septic Rats

Dantrolene: effects on abnormal intracellular Ca2+ handling and inotropy in postinfarcted rat myocardium

SERCA1 Attenuates Diaphragm Relaxation and Uptake Rate of SERCA in Rats with Acute Sepsis.

The molecular mechanism of sepsis-induced diaphragm dysfunction

Protective role of pretreatment with Anisodamine against sepsis-induced diaphragm atrophy via inhibiting JAK2/STAT3 pathway

Magnesium sulfate ameliorates sepsis-induced diaphragm dysfunction in rats via inhibiting HMGB1/TLR4/NF-κB pathway.

Dexmedetomidine May Produce Extra Protective Effects on Sepsis-induced Diaphragm Injury.

Slowed Relaxation of Diaphragm in Septic Rats is Associated with Reduced Expression of Sarco‐endoplasmic Reticulum CA2+‐ATPase Genes SERCA1 and SERCA2

Early Administration of Cisatracurium Attenuates Sepsis-Induced Diaphragm Dysfunction in Rats

Hydrogen sulfide prevents diaphragm weakness in cecal ligation puncture-induced sepsis by preservation of mitochondrial function

Chronic Dantrolene Treatment Attenuates Cardiac Dysfunction and Reduces Atrial Fibrillation Inducibility in a Rat Myocardial Infarction Heart Failure Model

MitoTEMPOL, a mitochondrial targeted antioxidant, prevents sepsis-induced diaphragm dysfunction

Necrostatin-1 can inhibit the necroptosis and improve diaphragm function in the sepsis mice sepsis by cecal ligation and puncture

Neuregulin-1β Protects the Rat Diaphragm During Sepsis Against Oxidative Stress and Inflammation by Activating the PI3K/Akt Pathway

Neuregulin-1β Attenuates Sepsis-Induced Diaphragm Atrophy by Activating the PI3K/Akt Signaling Pathway.

Effects of Levosimendan on Diaphragmatic Dysfunction in Patients with Sepsis

Beneficial Effect of Intermedin 1-53 in Septic Shock Rats: Contributions of Rho Kinase and BKCA Pathway-Mediated Improvement in Cardiac Function

Diaphragmatic dysfunction in sepsis due to severe acute pancreatitis complicated by intra-abdominal hypertension

Disruption of Calcium Homeostasis in Cardiomyocytes Underlies Cardiac Structural and Functional Changes in Severe Sepsis